Taichung, Taiwan

Kai-Wen Kan

This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: China Medical University Hospital, China Medical University, Shine-On Biomedical Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai-Wen Kan. Retrieved from https://idiyas.com/inventor/kai-wen-kan-eg1fj3xj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.4

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kai-Wen Kan

Introduction

Kai-Wen Kan is an inventor based in Taichung, Taiwan. He has contributed to the field of medical research, particularly in drug delivery systems. Although he currently holds no granted patents, his work is focused on enhancing the efficiency of drug loading into extracellular vesicles.

Latest Patent Applications

1. **Method for Enhancing the Efficiency of Drug Loading into Extracellular Vesicles and Medicinal Products Thereof** - This application describes a method for improving drug loading efficiency into extracellular vesicles. It involves the preparation of drug-loaded extracellular vesicles by establishing an ammonium sulfate concentration gradient using a balanced crystalloid solution. This approach facilitates the efficient encapsulation of a target drug within extracellular vesicles while maintaining stability in the balanced crystalloid environment.

2. **Exosomes for Treating Glioblastoma Multiforme and Manufacturing Method Thereof** - This application presents a drug carrier with the property of crossing the blood-brain barrier. It comprises an extracellular vesicle with a human leukocyte antigen-G antibody on its surface. This carrier can serve as a pharmaceutical composition for promoting apoptosis of brain tumor cells, inhibiting the growth of brain tumor cells, or reducing the expression of O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells. These effects contribute to the treatment of glioblastoma multiforme (GBM).

Conclusion

Kai-Wen Kan is an innovative inventor whose research focuses on improving drug delivery systems, particularly for challenging medical conditions like glioblastoma multiforme. His latest patent applications reflect his commitment to advancing medical science through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…